When figures from a variety of countries indicate reoperation rates in early breast cancer
are up to three times higher at some centres than others, something is clearly not right.
In this Cutting Edge, we look at some of the reasons behind this disparity and examine
the case for enforcing international consensus guidelines and quality control.

 What do you think?

• Are women being subjected to unnecessary reoperations to achieve surgical margins
  that cannot be justified by current knowledge about the likelihood of recurrence?
• Would stricter guidelines and quality control for pathology and surgery help?

•  You can read the article here. Press the comment button at the end and share your views.